Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG's Daniel O'Day as its new chief executive, tapping an industry veteran to fill a management vacuum.
Gilead Sciences snares Roche veteran O'Day as CEO
Reviewed by jenisht
on
December 10, 2018
Rating: 5
No comments: